Hakodate National Hospital
In research, Hakodate National Hospital stands highest in Medicine (#9,002 of 10,443 worldwide) and Health Sciences (#10,627 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine, Surgery and Medicine — Pulmonary and Respiratory Medicine is 12.0× its share of world research.
- World rank, 2022–2025
- #25,621 of 28,054 · #30,047 all time
- Rank in Japan
- #903 of 1,070
- Research works
- 826 ▲ 77% vs 2013–17
- Citations
- 5.1k 6.2 per fractional work
- Top-10% rate
- 4.2% record average 16.5%
- Open access
- 52% world 28%
What is Hakodate National Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #9,002 of 10,443 | 4.4% | 160 | #9422 | |
| Health SciencesDomain | #10,627 of 11,982 | 4.4% | 163 | #12096 |
Each strip is that field’s whole ranked pool, with the notch where Hakodate National Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Hakodate National Hospital specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 12.0× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 33.3 works12×
- SurgerySubfield · 35.4 works8.3×
- MedicineField · 160.3 works4.6×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.6×. Every wedge is a field page.
- Medicine 4.6×
- Immunology and Microbiology 1.9×
- Pharmacology, Toxicology and Pharmaceutics 1.1×
- Veterinary 1.0×
- Biochemistry, Genetics and Molecular Biology 0.9×
- Neuroscience 0.6×
- Health Professions 0.5×
- Nursing 0.4×
- Chemistry 0.2×
- Dentistry 0.1×
- Economics, Econometrics and Finance 0.1×
- Environmental Science 0.0×
- Physics and Astronomy 0.0×
- Engineering 0.0×
- Mathematics 0.0×
- Agricultural and Biological Sciences 0.0×
- Materials Science 0.0×
- Social Sciences 0.0×
Who are the top researchers at Hakodate National Hospital?
Ranked on the composite score, Noriko Kimura, Minoru Umehara and Koichi Haraguchi lead among researchers whose main affiliation is Hakodate National Hospital.
- 1 Noriko Kimura Japan · #370,223 worldwide 134 citations · 56 works
- 2 Minoru Umehara Japan · #615,462 worldwide 22 citations · 25 works
- 3 Koichi Haraguchi Japan · #794,454 worldwide 34 citations · 20 works
- 4 Yosuke Tsuruga Japan · #855,956 worldwide 11 citations · 15 works
- 5 Yoshiya Yamamoto Japan · #974,310 worldwide 24 citations · 20 works
- 6 Kimitoshi Kubo Japan · #1,040,473 worldwide 17 citations · 25 works
- 7 Ken Imaizumi Japan · #1,193,565 worldwide 4 citations · 17 works
- 8 Kazuya Yonezawa Japan · #1,342,674 worldwide 36 citations · 20 works
- 9 Akinori Takagane Japan · #1,349,143 worldwide 20 citations · 23 works
- 10 Aya Sato Japan · #1,403,281 worldwide 10 citations · 22 works
Which keywords describe research at Hakodate National Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Chemotherapy, Clinical Practice Guidelines, Treatment, Diagnosis, Immunotherapy, Surgical Management and Survival Analysis.
- Preoperative Chemoradiotherapy
- Immune Checkpoint Blockade
- Adults
- Sunitinib
- PDGFRA Mutations
- Breast Cancer
- Guidelines
- Children
- Molecular Profiling
- Metastatic Gastric Cancer
- Neoadjuvant Chemotherapy
- PET Imaging
- Complications
- Tumor Microenvironment
- Molecular Characterization
- Prognostic Factors
- Survival Analysis
- Immunotherapy
- Clinical Practice Guidelines
- Chemotherapy
- Epidemiology
- Treatment
- Diagnosis
- Surgical Management
- Adjuvant Therapy
- Gastric Cancer
- Inflammation
- Endoscopic Resection
- Neoadjuvant Therapy
- Management
- Lymph Node Dissection
- Imatinib Mesylate
- Prognosis
- Pathogenesis
- Immunohistochemistry
- Prognostic Markers
- Radiotherapy
- Therapeutic Targets
- Imaging
- PD-1 and PD-L1
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology27▲ 3.8×62 topics
- Chemotherapy18▲ 14×20 topics
- Treatment16▲ 7.1×28 topics
- Clinical Practice Guidelines15▲ 15×14 topics
- Diagnosis15▲ 8.8×25 topics
- Immunotherapy12▲ 8.9×18 topics
- Surgical Management10▲ 13×13 topics
- Survival Analysis10▲ 19×6 topics
- Adjuvant Therapy9▲ 40×2 topics
- Prognostic Factors9▲ 11×11 topics
- Gastric Cancer9▲ 42×3 topics
- Molecular Characterization8▲ 26×4 topics
- Inflammation8▲ 2.2×41 topics
- Tumor Microenvironment8▲ 10×7 topics
- Endoscopic Resection8▲ 45×2 topics
- Complications8▲ 8.7×11 topics
- Neoadjuvant Therapy8▲ 19×5 topics
- PET Imaging8▲ 25×4 topics
- Management7▲ 5.2×20 topics
- Neoadjuvant Chemotherapy7▲ 45×2 topics
- Lymph Node Dissection7▲ 64×1 topic
- Metastatic Gastric Cancer7▲ 64×1 topic
- Imatinib Mesylate6▲ 72×2 topics
- Molecular Profiling6▲ 37×3 topics
- Prognosis6▲ 11×8 topics
- Children6▲ 15×4 topics
- Pathogenesis6▲ 6.2×12 topics
- Guidelines6▲ 6.7×11 topics
- Immunohistochemistry6▲ 42×3 topics
- Breast Cancer5▲ 12×8 topics
- Prognostic Markers5▲ 27×3 topics
- PDGFRA Mutations5▲ 103×1 topic
- Radiotherapy5▲ 7.3×8 topics
- Sunitinib5▲ 103×1 topic
- Therapeutic Targets5▲ 18×5 topics
- Adults5▲ 43×2 topics
- Imaging4▲ 9.4×4 topics
- Immune Checkpoint Blockade4▲ 21×1 topic
- PD-1 and PD-L14▲ 21×1 topic
- Preoperative Chemoradiotherapy4▲ 29×2 topics
Which research topics does Hakodate National Hospital publish most on?
By volume in 2022–2025: Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment, Cancer Immunotherapy and Biomarkers and Metastasis and carcinoma case studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 7 works
- 2 Gastrointestinal Tumor Research and Treatment Gastroenterology 5 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 4 Metastasis and carcinoma case studies Pulmonary and Respiratory Medicine 4 works
- 5 Gastrointestinal disorders and treatments Surgery 4 works
- 6 Esophageal and GI Pathology Surgery 3 works
- 7 Colorectal Cancer Surgical Treatments Oncology 3 works
- 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 9 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 10 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Hakodate National Hospital's research output changed?
Output in 2018–2022 was 77% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hakodate
- Future University Hakodate
- Hakodate Central General Hospital
- Hakodate University
- National Institute of Technology, Hakodate College
- Hakodate Junior College
- Hakodate Otani College
- Hakodate Shirayuri Gakuen
- Hakodate City Museum
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.